News
Artbits |
4 May
Labiana ha hecho público su informe de resultados mostrando un incremento del 1,6% en su facturación en 2022. Apúntate al Webinar.
Labiana |
14 March
Labiana, el primer laboratorio veterinario español cotizado en Bolsa, ha reforzado su división especializada en pequeños animales.
Ataxxa, distribuido por Labiana, autorizado para la reducción del riesgo de infección por Leishmania
Labiana |
17 February
Ataxxa, medicamento distribuido por Labiana, autorizado para la reducción del riesgo de infección por Leishmania.
Labiana |
15 December
Se trata de un anti-inflamatorio que puede prescribirse como coadyuvante en el tratamiento de enfermedades que cursen con dolor e inflamación en bovino, porcino, perros y gatos. Su principio activo es el ácido tolfenámico
LABIANA REACHES THE FINAL STAGES OF ITS IPO AND MARKS A MILESTONE IN THE SPANISH VETERINARY INDUSTRY
Labiana |
23 May
Labiana Health S.A. ("Labiana" or the "Group") is an integrated and independent animal and human health platform with international presence,
Labiana |
22 October
From Labiana Pharmaceuticals we are proud to announce the expansion of our production facilities with a new line for liquid ampoules
Labiana |
28 September
After almost 2 years of virtual exhibitions, Labiana team is keen to see you again at the main pharmaceutical and
Labiana |
9 June
Introduction Myxomatosis is a widespread and lethal viral disease of the common rabbit (Oryctolagus cuniculus) caused by the Myxoma virus
Labiana |
22 April
World Veterinary Day is an annual event that was created and established to promote and highlight the lifesaving work performed
Labiana |
10 March
Veterinarski Zavod Subotica, a leading animal health product manufacturing company in Serbia also a reference throughout the Balkan peninsula, celebrates